Reconstruction of the dentato-rubro-thalamic tract based on the anatomy of the rubral wing
Objective: We investigated reconstructing the entire dentato-rubro-thalamic tract (DRT) by an anatomical “rubral wing”-based tractography and compare its correlation with clinical outcomes to those of…The spectrum of GBA mutations in the Korean population with Parkinson’s disease
Objective: We investigated the mutation spectrum of glucocerebrosidase (GBA) gene in Korean patients with Parkinson’s disease (GBA-PD). Background: Mutations in the GBA gene represent important…Hand to mouth: differences between musicians’ hand and embouchure dystonia
Objective: To assess differences in playing ability and outcome of patients with Musician’s Hand (FHD) and Embouchure Dystonia (ED). Background: Musician’s Dystonia (MD) is a…Gut microbiota dysbiosis in Parkinson’s disease patients: a potential biomarker of disease severity and progression?
Objective: To investigate gut microbiota alterations in Parkinson's disease (PD) along disease progression. Background: Gut microbiota dysbiosis is considered a hallmark in PD1. However, it is…Speech, gait and vestibular instrumental assessment in CANVAS: a case series.
Objective: To describe through a systematic clinical-instrumental approach speech, gait and vestibular alterations in cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Background: CANVAS…A new era in etiologies of chorea
Objective: To describe the prevalence, presentation and etiology of chorea (including ballism and athetosis) in adults as seen at a tertiary medical center in Israel…NR-SAFE: a randomized, double-blind safety trial of high dose nicotinamide riboside in Parkinson’s disease.
Objective: To determine the safety of oral nicotinamide riboside (NR) 3000 mg daily for 4 weeks in Parkinson’s disease (PD). Secondary objectives: To assess NRs…Expiratory strength in Parkinson’s disease patients? Does time matter?
Objective: To assess the effectiveness of cough in Parkinson’s Disease (PD) patients in mild, moderate and severe disease stages. Background: Parkinson's Disease is the second…Clinico-genetic analysis of patients with Parkinson’s disease and GBA mutations from a tertiary care teaching centre in India
Objective: To describe the clinico-genetic association of PD patients with heterozygous GBA mutations (PDwG). Background: Parkinson’s disease (PD) is currently understood to be the outcome…A Retrospective Review of Amantadine in Progressive Supranuclear Palsy
Objective: To determine the efficacy and tolerability of amantadine in Progressive supranuclear palsy (PSP). Background: PSP is one of the most common atypical parkinsonian disorders,…
- « Previous Page
- 1
- …
- 157
- 158
- 159
- 160
- 161
- …
- 186
- Next Page »